Effect of rhGM-CSF on the Healing of Venous Leg Ulcers
Clinical trial NCT04823962 · UNKNOWN
Trial details
- NCT number
- NCT04823962
- Sponsor
- Reponex Pharmaceuticals A/S
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-11
- Primary completion
- 2023-12-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.